New Drug Pricing Deal Announced by Trump Administration
Viewers of *World News Tonight* with David Muir were surprised this week as the anchor detailed a new agreement between the administration of former President Donald Trump and two major…
Eli Lilly and Novo Nordisk Set to Cut Obesity Drug Prices
Eli Lilly and Novo Nordisk are poised to announce agreements with the White House that could significantly reduce the cost of their obesity medications. Reports indicate that the companies will…
Trump Urges Drug Companies to Cut Prices, Advocates Market Solutions
President Donald Trump has taken a firm stance on prescription drug prices, sending letters to 17 pharmaceutical companies urging them to lower their prices to match the lowest rates offered…
Novo Nordisk Faces Challenges as Eli Lilly Boosts AI Initiative
A series of developments are reshaping the landscape of the pharmaceutical industry, as major players grapple with challenges and opportunities. Novo Nordisk, a leader in diabetes care, continues to navigate…
Novo Nordisk Restructures Amid Lowered Profit Growth Forecasts
BREAKING: Novo Nordisk has just announced a significant restructuring plan aimed at revitalizing its long-term investment strategy in diabetes and obesity treatments. The pharmaceutical giant is adjusting its 2025 operating…
Eli Lilly Partners with Superluminal in $1.3 Billion Obesity Deal
Eli Lilly has entered into a significant partnership with Superluminal, a machine learning-focused startup, to advance its research and development efforts in the field of obesity. The agreement is valued…